Clinical Trial Update: Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype

View source ↗

Summary

A clinical trial update from Samsung Medical Center on using a genome-wide pharmacogenetic SNP array to predict chemoresponse and survival in patients with acut…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Snippet

Sponsor: Samsung Medical Center | Conditions: Myeloid Leukemia | Status: UNKNOWN